resTORbio (resTORbio) EBITDA Margin % : 0.00% (As of Jun. 2020)

View and export this data going back to 2018. Start your Free Trial

What is resTORbio EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. resTORbio's EBITDA for the three months ended in Jun. 2020 was $-5.62 Mil. resTORbio's Revenue for the three months ended in Jun. 2020 was $0.00 Mil. Therefore, resTORbio's EBITDA margin for the quarter that ended in Jun. 2020 was 0.00%.

resTORbio EBITDA Margin % Historical Data

The historical data trend for resTORbio's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

resTORbio EBITDA Margin % Chart

resTORbio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

EBITDA Margin %

resTORbio Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
EBITDA Margin %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of resTORbio's EBITDA Margin %

For the Biotechnology subindustry, resTORbio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

resTORbio's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, resTORbio's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where resTORbio's EBITDA Margin % falls into.

resTORbio EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

resTORbio's EBITDA Margin % for the fiscal year that ended in Dec. 2019 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2019 )	/	Revenue (A: Dec. 2019 )
	=	-85.332	/	0
	=	%

resTORbio's EBITDA Margin % for the quarter that ended in Jun. 2020 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2020 )	/	Revenue (Q: Jun. 2020 )
	=	-5.618	/	0
	=	%

resTORbio (NAS:TORC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

resTORbio EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of resTORbio's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

resTORbio (resTORbio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » resTORbio Inc (NAS:TORC) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Boylston Street, 13th Floor, Boston, MA, USA, 02116

Website

https://www.restorbio.com

resTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. The company focuses on the mechanistic target of rapamycin (mTOR) pathway which regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1. It is also involved in the development of RTB101 which is a small molecule, potent TORC1 inhibitor. The company's pipeline products include RTB101 and RTB101+ everolimus.